PCI Biotech Holding ASA (4QG) Stock Statistics & Valuation Metrics

PCI Biotech Holding ASA has a market cap or net worth of €4.53M. The enterprise value is €17.61M.

PCI Biotech Holding ASA has 37,326,390 shares outstanding. The number of shares has decreased by -2.65% in one year.

PCI Biotech Holding ASA’s return on equity (ROE) is -0.70 and return on invested capital (ROIC) is -75.48%.

The current PE Ratio of PCI Biotech Holding ASA is ―. PCI Biotech Holding ASA’s PEG ratio is ―.

In the last 12 months, PCI Biotech Holding ASA had revenue of 6.74M and earned -16.42M in profits. Earnings per share was -0.44.

In the last 12 months, operating cash flow was -13.76M and capital expenditures 0.00, giving a free cash flow of -13.76M billion.

PCI Biotech Holding ASA pays an annual dividend of ―, resulting in a dividend yield of ―

PCI Biotech Holding ASA upcoming earnings date is Aug 29, 2025, Before Open (Confirmed).

PCI Biotech Holding ASA as a current ratio of 3.98, with Debt / Equity ratio of 1.43%

In the past 12 months, PCI Biotech Holding ASA has paid 0.00 in taxes.

PCI Biotech Holding ASA EV to EBITDA ratio is -1.00, with an EV/FCF ratio of -1.28.

PCI Biotech Holding ASA has €27.07M in cash and marketable securities with ― in debt, giving a net cash position of -€26.73M billion.

Gross margin is 100.00%, with operating margin of -266.59%, and net profit margin of -243.76%.

The average price target for PCI Biotech Holding ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―